Literature DB >> 14973380

Historical and epidemiologic background of human premalignant breast disease.

D L Page1, R A Jensen, J F Simpson, W D Dupont.   

Abstract

Premalignant breast disease in humans is a concept that admits to a broad range of elements and possible determinants predicting the likelihood of developing breast cancer. Most of these elements are relative, such as the risk of breast cancer for women that is 130 times that of men and peaks at a younger age by about 10 years. Breast cancer is clearly a stochastic, multifactorial process that evolves over many years in which we must make predictions by likelihood. This review will present the most specially defined and reliably proven of these elements, highlighting anatomic and molecular factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 14973380     DOI: 10.1023/a:1009521726605

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  36 in total

1.  Preneoplastic lesions in the human breast.

Authors:  H M Jensen; J R Rice; S R Wellings
Journal:  Science       Date:  1976-01-23       Impact factor: 47.728

2.  Biomarkers in benign breast disease: risk factors for breast cancer.

Authors:  D C Allred; S G Hilsenbeck
Journal:  J Natl Cancer Inst       Date:  1998-09-02       Impact factor: 13.506

3.  Benign breast diseases and premalignant breast disease.

Authors:  D L Page; W D Dupont
Journal:  Arch Pathol Lab Med       Date:  1998-12       Impact factor: 5.534

4.  Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy.

Authors:  M Kasami; C L Vnencak-Jones; S Manning; W D Dupont; D L Page
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

Review 5.  ABC of breast diseases. Congenital problems and aberrations of normal breast development and involution.

Authors:  J M Dixon; R E Mansel
Journal:  BMJ       Date:  1994-09-24

Review 6.  Anatomic markers of human premalignancy and risk of breast cancer.

Authors:  D L Page; W D Dupont
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

7.  Invasive breast cancer risk in women with sclerosing adenosis.

Authors:  R A Jensen; D L Page; W D Dupont; L W Rogers
Journal:  Cancer       Date:  1989-11-15       Impact factor: 6.860

8.  Long-term risk of breast cancer in women with fibroadenoma.

Authors:  W D Dupont; D L Page; F F Parl; C L Vnencak-Jones; W D Plummer; M S Rados; P A Schuyler
Journal:  N Engl J Med       Date:  1994-07-07       Impact factor: 91.245

9.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

10.  Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions.

Authors:  D Weinstat-Saslow; M J Merino; R E Manrow; J A Lawrence; R F Bluth; K D Wittenbel; J F Simpson; D L Page; P S Steeg
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

View more
  6 in total

1.  Early Breast Cancer Precursor Lesions: Lessons Learned from Molecular and Clinical Studies.

Authors:  Hans-Peter Sinn; Zeinab Elsawaf; Birgit Helmchen; Sebastian Aulmann
Journal:  Breast Care (Basel)       Date:  2010-08-23       Impact factor: 2.860

2.  Clinicopathologic characteristics and prognosis for molecular subtypes in low-grade breast carcinoma: comparison with grade one invasive ductal carcinoma-not otherwise specified.

Authors:  Shuling Wang; Weidong Li; Ning Liu; Tongxian Zhang; Han Liu; Junjun Liu; Fen Liu; Wei Zhang; Estifanos P Gebreamlak; Yun Niu
Journal:  Med Oncol       Date:  2012-02-07       Impact factor: 3.064

3.  History of benign breast disease and risk of breast cancer among women in China: a case-control study.

Authors:  Tsogzolmaa Dorjgochoo; Sandra L Deming; Yu-Tang Gao; Wei Lu; Ying Zheng; Zhixian Ruan; Wei Zheng; Xiao Ou Shu
Journal:  Cancer Causes Control       Date:  2008-03-18       Impact factor: 2.506

4.  Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions.

Authors:  Giovanni P Burrai; Sulma I Mohammed; Margaret A Miller; Vincenzo Marras; Salvatore Pirino; Maria F Addis; Sergio Uzzau; Elisabetta Antuofermo
Journal:  BMC Cancer       Date:  2010-04-22       Impact factor: 4.430

5.  The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions.

Authors:  G Terry; L Ho; P Londesborough; C Duggan; A Hanby; J Cuzick
Journal:  Br J Cancer       Date:  2006-12-12       Impact factor: 7.640

6.  Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening.

Authors:  R Rawal; J Lorenzo Bermejo; K Hemminki
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.